Person:
ELÇİOĞLU, ÖMER CELAL

Loading...
Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
Organizational Unit
Job Title
First Name
ÖMER CELAL
Last Name
ELÇİOĞLU
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 98
  • PublicationOpen Access
    Comparative Evaluation of Orthostatic Hypotension in Patients with Diabetic Nephropathy.
    (2021-07-20T00:00:00Z) Aytaş, Gamze; Elçioğlu, Ömer C; Kazancıoğlu, Rümeyza; Gürsu, Meltem; Artan, A Serra; Yabacı, Ayşegül; Soysal, PINAR; Bilgi, Kadir; Özçelik, Semra; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; YABACI TAK, AYŞEGÜL; SOYSAL, PINAR; ÖZÇELİK, SEMRA
    Introduction: Orthostatic hypotension (OH) affects 5-20% of the population. Our study investigates the presence of OH in diabetic nephropathy (DNP) patients and the factors affecting OH in comparison with nondiabetic chronic kidney disease (NDCKD) patients. Method: Patients presented to the nephrology clinic, and those who consented were included in the study. DNP was defined by kidney biopsy and/or clinical criteria. NDCKD patients of the same sex, age, and eGFR were matched to DNP patients. Demographic parameters and medications were obtained from the records. OH was determined by Mayo clinic criteria. The same researcher used an electronic device to measure blood pressure (BP). All samples were taken and analyzed the same day for biochemical and hematologic parameters and albuminuria. Results: 112 (51 F, 61 M, mean age: 62.56 ± 9.35 years) DNP and 94 (40 F, 54 M, mean age: 62.23 ± 10.08 years) NDCKD patients were included. There was no significant difference between DNP and NDCKD groups in terms of OH prevalence (70.5 vs. 61.7%, p = 0.181). Male patients had significantly higher OH prevalence than female patients (74.7 vs. 60.0%, p = 0.026). There was no significant difference in change in systolic BP between the groups (24.00 [10.00-32.00] mm Hg vs. 24.00 [13.75-30.25] mm Hg, p = 0.797), but the change in diastolic BP was significantly higher in the DNP group (8.00 [2.00-13.00] mm Hg vs. 6.00 [2.00-9.00] mm Hg, p = 0.025). In the DNP group, patients with OH had significantly higher uric acid levels than those without OH (7.18 ± 1.55 vs. 6.36 ± 1.65 mg/dL, p = 0.017). And, 73.7% of patients on calcium channel blockers developed OH (p = 0.015), and OH developed in 80.6% of 36 patients on alpha-blockers (p = 0.049). Conclusion: OH prevalence is very high in CKD, and etiology of CKD does not have a statistically significant effect on the frequency of OH, despite a difference that could be meaningful clinically. Therefore, patients with CKD are checked for OH, with or without concurrent diabetes mellitus. Evaluation of postural BP changes should be a part of nephrology practice.
  • PublicationMetadata only
    Hyperuricemia is associated with progression of IgA nephropathy
    (2015-04-01T00:00:00Z) BAKAN, Ali; ORAL, Alihan; Elcioglu, Omer Celal; TAKIR, Mumtaz; KOSTEK, Osman; OZKOK, Abdullah; BASCI, Semih; SUMNU, Abdullah; OZTURK, Savas; Sipahioglu, Murat; Turkmen, Aydin; VORONEANU, Luminita; COVIC, Adrian; Kanbay, Mehmet; ELÇİOĞLU, ÖMER CELAL
    IgA nephropathy (IgAN) is one of the world-s most common glomerular diseases. Hyperuricemia was recently defined as risk factor for chronic kidney disease. We aimed to investigate the impact of baseline serum uric acid levels on progression of IgAN.
  • PublicationMetadata only
    Düzenli Hemodiyaliz Tedavisi Alan Hastalarda Vücut Kitle İndeksinin Laboratuvar Parametreleri ile İlişkisi.
    (2017-10-15T00:00:00Z) SAYAN, CANAN; BÜLBÜL, ELİF; PEÇEN, MUSTAFA; GÜL, ELİF BUSE; DELİGÖZ BİLDACI, YELDA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    Mega Mesane; Batında Kitle Nedenlerinden Nadir Bir Olgu.
    (2017-10-10T00:00:00Z) DELİGÖZ BİLDACI, YELDA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    Otozomal Dominant Polikistik Böbrek Hastalığında Total Oksidan/Antioksidan Seviyelerin Böbrek Fonksiyonlarıyla İlişkisi
    (2021-10-13T00:00:00Z) Aris, Özlem; Büyükaydın, Banu; Artan, Ayşe Serra; Mirioğlu, Şafak; Gürsu, Meltem; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; MİRİOĞLU, ŞAFAK; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
  • PublicationMetadata only
    Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart - Review Study
    (2019-05-24T00:00:00Z) BAKAN, Ali; Oral, Alihan; ECDER, Sabahat Alisir; KUZGUN, Gulsah Sasak; Elcioglu, Omer Celal; demirci, Recep; Bahat, Kubra Aydin; ODABAS, Ali Riza; ELÇİOĞLU, ÖMER CELAL
    Background: Amyloidosis is a protein-misfolding disease characterized by the deposition of aggregated proteins in the form of abnormal fibrils that disrupt tissue structure, ultimately causing disease. Amyloidosis is very frequent in untreated familial Mediterranean fever (FMF) patients and it is the most important feature that determines the prognosis of FMF disease. The mean platelet volume (MPV) in FMF has been previously studied. However, whether MPV level in FMF patients is lower or higher compared to healthy controls remains a topic of ongoing debate. In this study, we aimed to investigate MPV values and to assess the correlation between MPV and proteinuria in patients with AA amyloidosis and AA amyloidosis secondary to familial Mediterranean fever (AA-FMF) through a retrospective chart-review.
  • PublicationMetadata only
    Doğru Kan Basinci Ölçümü İçin İki Yöntemin Karşilaştirilmasi: Manuel Ölçüm Ve Otomatik Cihaz İle Ölçüm.
    (2021-10-13T00:00:00Z) KUŞDOĞAN, ENES; ARTAN, AYŞE SERRA; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
  • PublicationMetadata only
    Otozomal Dominant Polikistik Böbrek Hastalarında Üriner Sistem Taşı Oluşumuna Eğilim Oluşturan Metabolik Faktörler
    (2021-10-13T00:00:00Z) Chasan, Onour; Artan, Ayşe Serra; Gürsu, Meltem; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; CHASAN, ONOUR; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
  • PublicationUnknown
    THE PREVALENCE, CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN TURKISH ADULTS: THE DATA FROM TSN-GOLD (TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES) WORKING GROUP
    (2020-06-01T00:00:00Z) KURULTAK, İLHAN; Gungor, Ozkan; Ozturk, Savas; Dirim, Ahmet Burak; EREN, NECMİ; Yenigun, Ezgi; Dal, Elbis Ahbap; DİNCER, Mevlüt Tamer; BORA, FEYZA; AKGÜR, SUAT; Sumnu, Abdullah; DURSUN, BELDA; SİPAHİ, SAVAŞ; Getinkaya, Hakki; ŞAHİN, İDRİS; ŞAHİN, GARİP; Yilmaz, Murvet; Vatansever, Bulent; AYDIN, EMRE; ULU, MEMNUNE SENA; Gundogan, Ali; UstOndag, Sedat; Sayarlioglu, Hayriye; Sahin, Gizem Kumru; ELÇİOĞLU, Ömer Celal; Aydin, Zeki; Selcyk, Nedim Yilmaz; ÖNAL, CEREN; Oruc, Meric; Kucuk, Mehmet; Aktas, Nimet; DERİCİ, ÜLVER; SÜLEYMANLAR, GÜLTEKİN; ELÇİOĞLU, ÖMER CELAL
  • PublicationUnknown
    Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia
    (2015-12-01T00:00:00Z) TAKIR, Mumtaz; KOSTEK, Osman; OZKOK, Abdullah; Elcioglu, Omer Celal; BAKAN, Ali; EREK, Aybala; MUTLU, Hasan Huseyin; TELCI, Ozge; SEMERCI, Aysun; ODABAS, Ali Riza; AFSAR, Baris; SMITS, Gerard; ALANASPA, Miguel; SHARMA, Shailendra; JOHNSON, Richard J.; Kanbay, Mehmet; ELÇİOĞLU, ÖMER CELAL
    Background Hyperuricemia is an independent predictor of impaired fasting glucose and type 2 diabetes, but whether it has a causal role in insulin resistance remains controversial. Here we tested the hypothesis that lowering uric acid in hyperuricemic nondiabetic subjects might improve insulin resistance.